Voxel-based morphometry in Alzheimer’s disease

References

• Ferri CP, Prince M, Brayne C et al. Alzheimer’s Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet366(9503), 2112–2117 (2005).
   PubMed Web of Science ®Google Scholar
• Kawas CH, Corrada MM. Alzheimer’s and dementia in the oldest-old: a century of challenges. Curr. Alzheimer Res.3(5), 411–419 (2006).
   PubMedGoogle Scholar
• Jönsson L, Eriksdotter Jönhagen M, Kilander L et al. Determinants of costs of care for patients with Alzheimer‘s disease. Int. J. Geriatr. Psychiatry21(5), 449–459 (2006).
   PubMed Web of Science ®Google Scholar
• Gatz M, Reynolds CA, Fratiglioni L et al. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry63(2), 168–174 (2006).
   PubMed Web of Science ®Google Scholar
• Teipel SJ, Meindl T, Grinberg L, Heinsen H, Hampel H. Novel MRI techniques in the assessment of dementia. Eur. J. Nucl. Med. Mol. Imaging35(Suppl. 1), S58–S69 (2008).
   PubMed Web of Science ®Google Scholar
• Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology57, 1669–1674 (2001).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Shiung MM, Gunter JL et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology62, 591–600 (2004).
   PubMed Web of Science ®Google Scholar
• Wang L, Miller JP, Gado MH et al. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage30, 52–60 (2006).
   PubMedGoogle Scholar
• Apostolova LG, Dutton RA, Dinov ID et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch. Neurol.63, 693–699 (2006).
   PubMedGoogle Scholar
• Ridha BH, Barnes J, Bartlett JW et al. Tracking atrophy progression in familial Alzheimer’s disease: a serial MRI study. Lancet Neurol.5, 828–834 (2006).
   PubMed Web of Science ®Google Scholar
• Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab.10(4), 458–466 (1990).
   PubMed Web of Science ®Google Scholar
• Wright IC, McGuire PK, Poline JB et al. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage2(4), 244–252 (1995).
   PubMed Web of Science ®Google Scholar
• Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage4(3 Pt 1), 223–235 (1996).
   PubMed Web of Science ®Google Scholar
• Xie S, Xiao JX, Gong GL et al. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology66(12), 1845–1849 (2006).
   PubMed Web of Science ®Google Scholar
• Rose SE, Janke AL, Chalk JB. Gray and white matter changes in Alzheimer’s disease: a diffusion tensor imaging study. J. Magn. Reson. Imaging27(1), 20–26 (2008).
   Google Scholar
• Ashburner J, Friston KJ. Voxel-based morphometry – the methods. Neuroimage11(6), 805–821 (2000).
   PubMed Web of Science ®Google Scholar
• Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage14(1), 21–36 (2001).
   PubMed Web of Science ®Google Scholar
• Plassman BL, Langa KM, Fisher GG et al. Prevalence of cognitive impairment without dementia in the United States. Ann. Intern. Med.148(6), 427–434 (2008).
   PubMed Web of Science ®Google Scholar
• Rombouts SA, Barkhof F, Witter MP, Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer’s disease. Neurosci. Lett.285(3), 231–233 (2000).
   PubMed Web of Science ®Google Scholar
• Baron JC, Chételat G, Desgranges B et al.In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease. Neuroimage14(2), 298–309 (2001).
   PubMed Web of Science ®Google Scholar
• Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M. Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process? AJNR Am. J. Neuroradiol.22(9), 1680–1685 (2001).
   PubMed Web of Science ®Google Scholar
• Frisoni GB, Testa C, Zorzan A et al. Detection of grey matter loss in mild Alzheimer’s disease with voxel-based morphometry. J. Neurol. Neurosurg. Psychiatry73(6), 657–664 (2002).
   PubMed Web of Science ®Google Scholar
• Matsuda H, Kitayama N, Ohnishi T et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer’s disease. J. Nucl. Med.43(3), 304–311 (2002).
   PubMed Web of Science ®Google Scholar
• Busatto GF, Garrido GE, Almeida OP et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease. Neurobiol. Aging24(2), 221–231 (2003).
   PubMed Web of Science ®Google Scholar
• Karas GB, Burton EJ, Rombouts SA et al. A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry. Neuroimage18(4), 895–907 (2003).
   PubMed Web of Science ®Google Scholar
• Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study. J. Neurol. Neurosurg. Psychiatry76(1), 112–114 (2005).
   Google Scholar
• Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, Mori E. Comparison of gray matter and metabolic reduction in mild Alzheimer’s disease using FDG-PET and voxel-based morphometric MR studies. Eur. J. Nucl. Med. Mol. Imaging32(8), 959–963 (2005).
   PubMed Web of Science ®Google Scholar
• Ishii K, Kawachi T, Sasaki H et al. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer’s disease and assessment of diagnostic performance of z score images. AJNR Am. J. Neuroradiol.26(2), 333–340 (2005).
   PubMed Web of Science ®Google Scholar
• Pennanen C, Testa C, Laakso MP et al. A voxel based morphometry study on mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry76(1), 11–14 (2005).
   PubMed Web of Science ®Google Scholar
• Hirata Y, Matsuda H, Nemoto K et al. Voxel-based morphometry to discriminate early Alzheimer’s disease from controls. Neurosci. Lett.382(3), 269–274 (2005).
   PubMed Web of Science ®Google Scholar
• Hirao K, Ohnishi T, Matsuda H et al. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer’s disease using brain perfusion single-photon emission computed tomography. Nucl. Med. Commun.27(2), 151–156 (2006).
   Google Scholar
• Kawachi T, Ishii K, Sakamoto S et al. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging33(7), 801–809 (2006).
   Google Scholar
• Bozzali M, Filippi M, Magnani G et al. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology67(3), 453–460 (2006).
   PubMed Web of Science ®Google Scholar
• Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M. Four subgroups of Alzheimer’s disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage33(1), 17–26 (2006).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Jack CR Jr, Kantarci K et al. Imaging correlates of posterior cortical atrophy. Neurobiol. Aging28(7), 1051–1061 (2007).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Weigand SD, Shiung MM et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer’s disease. Brain130(Pt 3), 708–719 (2007).
   PubMedGoogle Scholar
• Di Paola M, Macaluso E, Carlesimo GA et al. Episodic memory impairment in patients with Alzheimer’s disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. J. Neurol.254(6), 774–781 (2007).
   PubMed Web of Science ®Google Scholar
• Samuraki M, Matsunari I, Chen WP et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer’s disease. Eur. J. Nucl. Med. Mol. Imaging34(10), 1658–1669 (2007).
   Google Scholar
• Matsunari I, Samuraki M, Chen WP et al. Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer’s disease: aging effect on diagnostic performance. J. Nucl. Med.48(12), 1961–1970 (2007).
   Google Scholar
• Josephs KA, Whitwell JL, Duffy JR et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology70(1), 25–34 (2008).
   PubMed Web of Science ®Google Scholar
• Kinkingnéhun S, Sarazin M, Lehéricy S, Guichart-Gomez E, Hergueta T, Dubois B. VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study. Neurology70(23), 2201–2211 (2008).
   Web of Science ®Google Scholar
• Whitwell JL, Jack CR Jr. Comparisons between Alzheimer disease, frontotemporal lobar degeneration, and normal aging with brain mapping. Top. Magn. Reson. Imaging16(6), 409–425 (2005).
   PubMedGoogle Scholar
• Thomann PA, Toro P, Santos V, Essig M, Schröder J. Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer’s disease. Brain Cogn.67, 88–93 (2008).
   PubMed Web of Science ®Google Scholar
• Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC. Neuropsychological correlates of whole brain atrophy in Alzheimer’s disease. Neuropsychologia46, 1732–1737 (2008).
   Google Scholar
• Karas G, Scheltens P, Rombouts S et al. Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study. Neuroradiology49(12), 967–976 (2007).
   Google Scholar
• Burton EJ, Karas G, Paling SM et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage17(2), 618–630 (2002).
   PubMedGoogle Scholar
• Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT. Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain127(Pt 4), 791–800 (2004).
   PubMed Web of Science ®Google Scholar
• Brenneis C, Wenning GK, Egger KE et al. Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodies. Neuroreport15(11), 1711–1714 (2004).
   Google Scholar
• Boxer AL, Rankin KP, Miller BL et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch. Neurol.60(7), 949–956 (2003).
   PubMed Web of Science ®Google Scholar
• Morris J. Mild Cognitive Impairment is early-stage Alzheimer’s disease: time to revise diagnostic criteria. Arch. Neurol.63, 15–16 (2006).
   PubMed Web of Science ®Google Scholar
• Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport13(15), 1939–1943 (2002).
   PubMed Web of Science ®Google Scholar
• Karas GB, Scheltens P, Rombouts SA et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer’s disease. Neuroimage23(2), 708–716 (2004).
   PubMed Web of Science ®Google Scholar
• Bell-McGinty S, Lopez OL, Meltzer CC et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch. Neurol.62(9), 1393–1397 (2005).
   PubMedGoogle Scholar
• Saykin AJ, Wishart HA, Rabin LA et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology67(5), 834–842 (2006).
   PubMed Web of Science ®Google Scholar
• Sorg C, Riedl V, Mühlau M et al. Selective changes of resting-state networks in individuals at risk for Alzheimer’s disease. Proc. Natl Acad. Sci. USA104(47), 18760–18765 (2007).
   PubMed Web of Science ®Google Scholar
• Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Int. Med.256, 240–246 (2004).
   PubMed Web of Science ®Google Scholar
• Petersen R. Mild cognitive impairment as a diagnostic entity. J. Int. Med.256, 183–194 (2004).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Petersen RC, Negash S et al. Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch. Neurol.64(8), 1130–1138 (2007).
   PubMed Web of Science ®Google Scholar
• Rozzini L, Chilovi BV, Conti M et al. Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. Int. J. Geriatr. Psychiatry22, 1217–1222 (2007).
   PubMed Web of Science ®Google Scholar
• Tyas SL, Salazar JC, Snowdon DA et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am. J. Epidemiol.165, 1231–1238 (2007).
   PubMed Web of Science ®Google Scholar
• Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J. Neurosci.23, 3295–3301 (2003).
   PubMed Web of Science ®Google Scholar
• Chételat G, Landeau B, Eustache F et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage27(4), 934–946 (2005).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Shiung MM, Przybelski SA et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology70(7), 512–520 (2008).
   PubMed Web of Science ®Google Scholar
• Karas G, Sluimer J, Goekoop R et al. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am. J. Neuroradiol.29(5), 944–949 (2008).
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Przybelski SA, Weigand SD et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain130(Pt 7), 1777–1786 (2007).
   PubMed Web of Science ®Google Scholar
• Chételat G, Fouquet M, Kalpouzos G et al. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry. Neuropsychologia46(6), 1721–1731 (2008).
   PubMed Web of Science ®Google Scholar
• Visser PJ, Scheltens P, Verhey FRJ. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? J. Neurol. Neurosurg. Psychiatry76, 1348–1354 (2005).
   PubMed Web of Science ®Google Scholar
• Teipel SJ, Pruessner JC, Faltraco F et al. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J. Neurol.253(6), 794–800 (2006).
   PubMed Web of Science ®Google Scholar
• Testa C, Laakso MP, Sabattoli F et al. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer’s disease. J. Magn. Reson. Imaging19(3), 274–282 (2004).
   PubMed Web of Science ®Google Scholar
• Hesse C, Rosengren L, Vanmechelen E et al. Cerebrospinal fluid markers for Alzheimer’s disease evaluated after acute ischemic stroke. J. Alzheimer Dis.2, 199–206 (2000).
   PubMedGoogle Scholar
• Blennow K, Zetterberg H, Minthon L et al. Longitudinal stability of CSF biomarkers in Alzheimer’s disease. Neurosci. Lett.419, 18–22 (2007).
   PubMedGoogle Scholar
• Hampel H, Bürger K, Pruessner JC et al. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch. Neurol.62, 770–773 (2005).
   PubMed Web of Science ®Google Scholar
• Diniz BS, Pinto JA, Forlenza OV. Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J. Biol. Psychiatry13, 1–11(2007).
   Google Scholar
• de Leon MJ, DeSanti S, Zinkowski R et al. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol. Aging27, 394–401 (2006).
   PubMed Web of Science ®Google Scholar
• Fjell AM, Walhovd KB, Amlien I et al. Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. AJNR Am. J. Neuroradiol.29, 1183–1189 (2008).
   Google Scholar
• Bouwman FH, Schoonenboom SN, van der Flier WM et al. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol. Aging28(7), 1070–1074 (2007).
   PubMedGoogle Scholar
• Jack Jr CR, Lowe VJ, Senjem ML et al.11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. Brain131, 665–680 (2008).
   Google Scholar
• Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease challenges to early intervention. Neurology69, 1622–1634 (2007).
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc. Natl Acad. Sci. USA103(15), 5644–5651 (2006).
   PubMed Web of Science ®Google Scholar
• Huang Y. Apolipoprotein E and Alzheimer disease. Neurology66(Suppl. 1), S79–S85 (2006).
   PubMedGoogle Scholar
• Juottonen K, Lehtovirta M, Helisalmi S, Riekkinen PJ Sr, Soininen H. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E epsilon4 allele. J. Neurol. Neurosurg. Psychiatry65, 322–327 (1998).
   PubMedGoogle Scholar
• Hashimoto M, Yasuda M, Tanimukai S et al. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer’s disease. Neurology57, 1461–1466 (2001).
   PubMed Web of Science ®Google Scholar
• Fleisher A, Grundman M, Jack Jr CR et al. Sex, apolipoprotein E ε4 status, and hippocampal volume in mild cognitive impairment. Arch. Neurol.62, 953–957 (2005).
   PubMed Web of Science ®Google Scholar
• den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MMB. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology59, 746–748 (2002).
   PubMed Web of Science ®Google Scholar
• Wishart HA, Saykin AJ, McAllister TW et al. Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele. Neurology67, 1221–1224 (2006).
   Google Scholar
• Lemaître H, Crivello F, Dufouil C et al. No ε4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage24, 1205–1213 (2005).
   Google Scholar
• Pennanen C, Testa C, Boccardi M et al. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Dement. Geriatr. Cogn. Disord.22, 60–66 (2006).
   Google Scholar
• Hämäläinen A, Tervo S, Grau-Olivares M et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage37, 1122–1131 (2007).
   PubMed Web of Science ®Google Scholar
• Hardy J. The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc. Natl Acad. Sci. USA94, 2095–2097 (1997).
   PubMed Web of Science ®Google Scholar
• Kennedy KM, Erickson KI, Rodrigue KM et al. Age-related differences in regional brain volumes: a comparison of optimized voxel-based morphometry to manual volumetry. Neurobiol. Aging (2008) (Epub ahead of print).
   Google Scholar
• Bookstein FL. “Voxel-based morphometry” should not be used with imperfectly registered images. Neuroimage14(6), 1454–1462 (2001).
   PubMed Web of Science ®Google Scholar
• Duran FSL, Valente AA, Miguel EC, Castro CC, Busatto GF. Risk of artifacts due to enlarged ventricles using voxel-based morphometry studies. Presented at: Organization for Human Brain Mapping Conference. Florence, Italy, 11–15 June 2006. Neuroimage (Suppl.), 31 (2006).
   Google Scholar
• Uchida RR, Del-Ben CM, Araújo D et al. Correlation between voxel based morphometry and manual volumetry in magnetic resonance images of the human brain. An. Acad. Bras. Cienc.80(1), 149–156 (2008).
   Google Scholar
• Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage38(1), 95–113 (2007).
   PubMed Web of Science ®Google Scholar
• Ashburner J, Friston KJ. Unified segmentation. Neuroimage26(3), 839–851 (2005).
   PubMed Web of Science ®Google Scholar
• Schaufelberger MS, Duran FL, Lappin JM et al. Grey matter abnormalities in Brazilians with first-episode psychosis. Br. J. Psychiatry51(Suppl.), S117–S122 (2007).
   Google Scholar
• Ewers M, Teipel SJ, Dietrich O et al. Multicenter assessment of reliability of cranial MRI. Neurobiol. Aging27(8), 1051–1059 (2006).
   PubMedGoogle Scholar
• Schnack HG, van Haren NE, Hulshoff Pol HE et al. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum. Brain Mapp.22(4), 312–320 (2004).
   Web of Science ®Google Scholar
• Teipel S, Ewers M, Dietrich O et al. Reliability of multicenter magnetic resonance imaging. Results of a phantom test and in vivo measurements by the German Dementia Competence Network. Nervenarzt77(9), 1086–1092, 1094–1095 (2006).
   Google Scholar
• Chaim TM, Duran FL, Uchida RR, Périco CA, de Castro CC, Busatto GF. Volumetric reduction of the corpus callosum in Alzheimer’s disease in vivo as assessed with voxel-based morphometry. Psychiatry Res.154(1), 59–68 (2007).
   PubMedGoogle Scholar
• Li S, Pu F, Shi F, Xie S, Wang Y, Jiang T. Regional white matter decreases in Alzheimer’s disease using optimized voxel-based morphometry. Acta Radiol.49(1), 84–90 (2008).
   PubMed Web of Science ®Google Scholar
• Villain N, Desgranges B, Viader F et al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer’s disease. J. Neurosci.28(24), 6174–6181 (2008).
   PubMed Web of Science ®Google Scholar
• Lao Z, Shen D, Xue Z, Karacali B, Resnick SM, Davatzikos C. Morphological classification of brains via high-dimensional shape transformations and machine learning methods. Neuroimage21(1), 46–57 (2004).
   PubMed Web of Science ®Google Scholar
• Fan Y, Shen D, Davatzikos C. Classification of structural images via high-dimensional image warping, robust feature extraction, and SVM. Med. Image Comput. Comput. Assist. Interv. Int. Conf. Med. Image Comput. Comput. Assist. Interv.8(Pt 1), 1–8 (2005).
   Google Scholar
• Davatzikos C, Fan Y, Wu X, Shen D, Resnick SM. Detection of prodromal Alzheimer’s disease via pattern classification of magnetic resonance imaging. Neurobiol. Aging29(4), 514–523 (2008).
   PubMed Web of Science ®Google Scholar
• Klöppel S, Stonnington CM, Chu C et al. Automatic classification of MR scans in Alzheimer’s disease. Brain131(Pt 3), 681–689 (2008).
   PubMed Web of Science ®Google Scholar
• Vemuri P, Gunter JL, Senjem ML et al. Alzheimer’s disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage39(3), 1186–1197 (2008).
   PubMedGoogle Scholar
• Mueller SG, Weiner MW, Thal LJ et al. Ways toward an early diagnosis in Alzheimer’s disease: the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement.1(1), 55–66 (2005).
   PubMedGoogle Scholar
• Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease. Alzheimers Dement.4(1), 38–48 (2008).
   PubMed Web of Science ®Google Scholar
• Frisoni GB, Whitwell JL. How fast will it go, doc? New tools for an old question from patients with Alzheimer disease. Neurology70(23), 2194–2195 (2008).
   Google Scholar
• Frisoni GB, Henneman WJ, Weiner MW et al. Alzheimer’s Disease Neuroimaging Initiative. The pilot European Alzheimer’s Disease Neuroimaging Initiative of the European Alzheimer’s Disease Consortium. Alzheimers Dement.4(4), 255–264 (2008).
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Bernstein MA, Fox NC et al. The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J. Magn. Reson. Imaging27(4), 685–691 (2008).
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS–ADRDA criteria. Lancet Neurol.6, 734–746 (2007).
   PubMed Web of Science ®Google Scholar
• Feldman HH, Ferris S, Winblad B et al. Effect of rivastigmine on delay to diagnosis of Alzheimer’s disease from mild cognitive impairment: the InDDEx study. Lancet Neurol.6, 501–512 (2007).
   PubMed Web of Science ®Google Scholar
• Jack Jr CR, Petersen RC, Grundman M et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol. Aging29, 1285–1295 (2008).
   Google Scholar